Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Peloruside A: a cytotoxic macrolide isolated from a marine sponge in New Zealand

Feb. 7, 2000

Cyclopentanones with antitumor and/or antiinflammatory activity synthesized at Shenyang university

Feb. 7, 2000

Lymph-targeted antitumor mitomycin C conjugate prepared at Chinese university

Feb. 7, 2000

Kyowa Hakko presents antitumor agents interacting with farnesyltransferase

Feb. 7, 2000

New antisense oligonucleotides targeting human SMAD3 from Isis

Feb. 7, 2000

Antitumor epothilone derivatives reported in patent literature by Schering AG

Feb. 4, 2000

COX-2 inhibitor now available for FAP indication

Feb. 4, 2000

Bexarotene now on the market in U.S.

Feb. 4, 2000

InKine files patent for novel antiangiogenic protein

Feb. 4, 2000

AEterna to commence phase III trial of AE-941 in second cancer indication

Feb. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.